Thursday, September 24, 2026

Charter Comm, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Charter Comm, Inc. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Charter Comm, Inc.

7.5% sales growth and 10.64% return on equity

Charter Communications, Inc., through its subsidiaries, provides cable services to residential and commercial customers in the United States.

Charter Comm, Inc.'s sales growth this year is expected to be 5.8% and 5.3% for next year.

Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 48.1B for the twelve trailing months.

Charter Comm, Inc.'s sales growth for the next quarter is 7.5%. The company's growth estimates for the present quarter and the next is 127.4% and 26.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.64%.

Volatility

Charter Comm, Inc.'s last day, last week, and last month's current volatility was 0.32%, 0.43%, and 0.99%, respectively.

Charter Comm, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.50% (day), 1.75% (last week), and 2.35% (last month), respectively.

Charter Comm, Inc.'s Stock Yearly Top and Bottom Value

Charter Comm, Inc.'s stock is valued at $617.10 at 17:22 EST, below its 52-week high of $681.71 and way above its 52-week low of $449.83.

Charter Comm, Inc.'s Moving Average

Charter Comm, Inc.'s worth is under its 50-day moving average of $622.03 and under its 200-day moving average of $630.06.

3. BioDelivery Sciences International, Inc.

17.5% sales growth and 28.89% return on equity

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally.

BioDelivery Sciences International, Inc.'s sales growth this year is expected to be 13.7% and 21% for next year.

Year-on-year quarterly revenue growth grew by 33.3%, now sitting on 156.47M for the twelve trailing months.

BioDelivery Sciences International, Inc.'s sales growth for the next quarter is 17.5%. The company's growth estimates for the present quarter and the next is 40% and 600%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.89%.

Volatility

BioDelivery Sciences International, Inc.'s last day, last week, and last month's current volatility was 1.45%, 2.26%, and 2.73%, respectively.

BioDelivery Sciences International, Inc.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.78% (day), 4.11% (last week), and 4.96% (last month), respectively.

BioDelivery Sciences International, Inc.'s Stock Yearly Top and Bottom Value

BioDelivery Sciences International, Inc.'s stock is valued at $3.45 at 17:22 EST, way under its 52-week high of $5.45 and way above its 52-week low of $3.04.

BioDelivery Sciences International, Inc.'s Moving Average

BioDelivery Sciences International, Inc.'s worth is way under its 50-day moving average of $3.89 and way below its 200-day moving average of $3.96.

4. Coca Cola Femsa S.A.B. de C.V.

30.6% sales growth and 8.22% return on equity

Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages.

Coca Cola Femsa S.A.B. de C.V. 's sales growth this year is anticipated to be 10.7% and 3.7% for next year.

Year-on-year quarterly revenue growth declined by 6.7%, now sitting on 181.52B for the twelve trailing months.

Coca Cola Femsa S.A.B. de C.V. 's sales growth for the next quarter is 30.6%. The company's growth estimates for the present quarter and the next is 8.2% and 65.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.22%.

Volatility

Coca Cola Femsa S.A.B. de C.V. 's last day, last week, and last month's current volatility was 0.65%, 0.87%, and 0.94%, respectively.

Coca Cola Femsa S.A.B. de C.V. 's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.00% (day), 1.73% (last week), and 2.01% (last month), respectively.

Coca Cola Femsa S.A.B. de C.V. 's Stock Yearly Top and Bottom Value

Coca Cola Femsa S.A.B. de C.V. 's stock is valued at $47.84 at 17:22 EST, under its 52-week high of $49.16 and way higher than its 52-week low of $36.16.

Coca Cola Femsa S.A.B. de C.V. 's Moving Average

Coca Cola Femsa S.A.B. de C.V. 's worth is higher than its 50-day moving average of $46.29 and above its 200-day moving average of $44.65.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Go Mainstream, But Trustworthy Data Access Lags Adoption
A wave of enterprise AI agent activity — fresh funding (Latitude's $35M Series A), a run of CB Insights CEO interviews spotlighting fintech- and healthcare-focused agent startups (Covecta, Penguin AI, Maisa AI), and major platform partnerships (Microsoft-Mistral, Manulife-Microsoft AI governance, Siemens-NVIDIA agentic EDA, Box's agent security controls) — signals agentic AI moving from pilot to production across financial and enterprise workflows. Yet Google Cloud's own research shows adoption is outrunning data readiness (companies average AI access to only 45% of their data, with 'data laggards' capped near 30%), while insider selling at incumbent C3.ai hints at mixed investor conviction even as the broader ecosystem accelerates.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,305 source documents archived
Query this data → isubstrate.com